Inquiry Basket
CAS No.: 16142-03-3
Cat No.: BADC-00975
Purity: > 98.0 %
4.5 
mPEG5-acetic acid serves as a key PEG linker component in ADC synthesis, enhancing hydrophilicity and stability of antibody-drug conjugates for efficient therapeutic payload attachment and controlled release.
Structure of 16142-03-3
* For research and manufacturing use only. We do not sell to patients.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
| Catalog | Product Name | CAS | Inquiry |
|---|---|---|---|
| BADC-00875 | m-PEG6-SS-PEG6-methyl | 1007386-15-3 | |
| BADC-00512 | m-PEG1-NHS ester | 1027371-75-0 | |
| BADC-00878 | mPEG6-azide | 1043884-49-6 | |
| BADC-00882 | m-PEG5-succinimidyl carbonate | 1058691-00-1 | |
| BADC-00883 | mPEG7-aldehyde | 1058691-77-2 | |
| BADC-00884 | m-PEG8-Ms | 1059588-19-0 | |
| BADC-00889 | m-PEG8-COOH | 1093647-41-6 | |
| BADC-00890 | mPEG4-bromide | 110429-45-3 | |
| BADC-00519 | m-PEG2-NHS ester | 1127247-34-0 | |
| BADC-00904 | m-PEG7-CH2CH2CHO | 1234369-95-9 |
mPEG5-acetic acid
Required fields are marked with *
mPEG5-acetic acid
Required fields are marked with *
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.
